Icario Names Healthcare Veteran Troy Jelinek Chief Commercial Officer
Former UnitedHealth Group Executive to Help Lead Growth in Health Plan and Provider MarketsMINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) --...
Year: 2022
XP Health Partners With Noyo to Effortlessly Connect with Benefits Administration Platforms and Insurance Carriers, Securely and at Scale
XP Health’s AI-powered Vision Platform to Deliver Enhanced Group Benefits with Noyo IntegrationSAN CARLOS, Calif. and SAN FRANCISCO, April 12, 2022...
Progenity to Become Biora Therapeutics as it Completes Transformation
Upcoming Change Reflects the Company’s Focus on Oral Delivery of BiotherapeuticsSAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc....
Cannabix Technologies to Present at International Association for Chemical Testing (IACT) Conference in Arizona
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
Healthy Extracts Expects Q1 2022 Net Revenue up 187% to Record $489,000, Driving First Profitable Quarter
LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based...
Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)
MALVERN, Pa., April 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and...
CytoDyn Announces Publication of Peer-Reviewed Paper, “Suppression of Human and Simian Immunodeficiency Virus Replication with the CCR5-Specific Antibody Leronlimab in Two Species”
VANCOUVER, Washington, April 12, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company...
IO Biotech Announces Initiation of Phase 2 Trial of IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) as First-Line Treatment in a Multi-Arm Basket Trial
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer...
Halo Elevate Officially Hits Shelves at Pet Supplies Plus
Halo’s Ground-Breaking Brand of Super Premium, Natural Pet Food will be Available at 600+ Pet Supplies Plus Locations Beginning in...
Panbela Announces Poster Presentation at American Association for Cancer Research:
The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancerMINNEAPOLIS, April 12, 2022 (GLOBE...
Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine Congress
LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines,...
TOMI Presents the SteraPak at RIA International Restoration Convention & Industry Expo
FREDERICK, Md., April 12, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes...
LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations
PASADENA, CA, April 12, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on...
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
FOR IMMEDIATE RELEASE All Four Proposals Approved NEW YORK, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:...
Hemostemix Inc. Announces Intellectual Property Due Diligence and Data Audit Completed
Calgary, Alberta--(Newsfile Corp. - April 12, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is...
Psyched Wellness to Participate in Upcoming Investor Conferences in April 2022
Toronto, Ontario--(Newsfile Corp. - April 12, 2022) - Psyched Wellness Ltd. (CSE:PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched")...
Masimo Closes Acquisition of Sound United
Leading Developer of Premium Consumer Sound and Home Integration Technologies Becomes Masimo Subsidiary IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced...
Tachyum Enhances Customer and Partner Experience with New Web Ticketing System
LAS VEGAS--(BUSINESS WIRE)--Tachyum™ today announced that it has launched enhancements to its online Customer & Partner Portal with the addition...
Scryb Reports on Partnership with FinTech Company; Commences Software Evaluation Period for Cybeats Cybersecurity Products
Toronto, Ontario--(Newsfile Corp. - April 12, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"), is...